相关实验视频
Updated: Aug 14, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.0K
装载有P4HA1 siRNA的多层奇托-凝颗粒抑制了质瘤的发展
Yiting Zhou1, Jiajia Tian2, Yi Zhu3,4
1Department of Intervention Therapy, The Affiliated Hospital of Jiangnan University, Wuxi, 214002, China.
Drug delivery and translational research
|September 4, 2023
概括
装载着prolyl-4-hydroxylase亚单元α1 (P4HA1) siRNA的奇托桑-凝微球有效地抑制了质瘤细胞的增殖和转移. 这种新的P4HA1 siRNA@CGM配方在质瘤治疗方面表现有前途.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 甲基4-基酶亚单元α1 (P4HA1) 与质瘤的进展有关.
- 向P4HA1为质瘤提供了潜在的治疗策略.
- 在体内,短干扰RNA (siRNA) 的不稳定性需要先进的传递系统.
研究的目的:
- 开发和评估载有P4HA1siRNA (P4HA1siRNA@CGM) 的奇托-凝微球 (CGM),用于结质瘤治疗.
- 评估P4HA1 siRNA@CGM.的稳定性,血液兼容性以及体外/体内疗效.
- 研究P4HA1 siRNA@CGM对质瘤细胞增殖,转移和血管生成的影响.
主要方法:
- 酸盐-凝微球是用P4HA1 siRNA配制的.
- 试验室试验包括MTT,殖民地形成,Transwell,伤口愈合,球和西部斑点.
- 在体内研究涉及放射性核素成像和Ki67/TUNEL染色在异种移植小鼠模型.
主要成果:
- P4HA1 siRNA@CGM表现出稳定性和血液兼容性.
- 在体外,P4HA1 siRNA@CGM显著抑制了结质瘤细胞的增殖,迁移,结质球形成和血管生成.
- 在体内,P4HA1 siRNA@CGM抑制了瘤生长,并在质瘤外移植中促进了细胞亡,与单独的P4HA1 siRNA相比,其疗效更高.
结论:
- P4HA1 siRNA@CGM是一种可行且有效的配方,可以抑制质瘤的进展.
- 开发的微球系统克服了siRNA的不稳定性,为质瘤提供了一个有前途的治疗方法.
- 使用P4HA1siRNA@CGM向P4HA1需要进一步的临床研究来治疗质瘤.
相关概念视频
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...